FR2741621B1
(fr)
*
|
1995-11-23 |
1998-02-13 |
Sanofi Sa |
Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant
|
FR2742148B1
(fr)
*
|
1995-12-08 |
1999-10-22 |
Sanofi Sa |
Nouveaux derives du pyrazole-3-carboxamide, procede pour leur preparation et compositions pharmaceutiques les contenant
|
DE19701277A1
(de)
*
|
1997-01-16 |
1998-07-23 |
Bayer Ag |
Verfahren zur Herstellung von 1-Alkyl-pyrazol-5-carbonsäureestern
|
EP0971588B1
(de)
*
|
1997-01-21 |
2004-03-17 |
Smithkline Beecham Corporation |
Neue cannabinoidrezeptor-modulatoren
|
FR2761265B1
(fr)
*
|
1997-03-28 |
1999-07-02 |
Sanofi Sa |
Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino-3-pyrazolecarboxamide, de ses sels et de leurs solvates
|
ATE367809T1
(de)
|
1998-04-21 |
2007-08-15 |
Us Health |
Cannabinoiden als antioxidantien und neuroschützende mittel
|
WO1999057106A1
(en)
*
|
1998-05-04 |
1999-11-11 |
The University Of Connecticut |
Novel analgesic and immunomodulatory cannabinoids
|
US7589220B2
(en)
*
|
1998-06-09 |
2009-09-15 |
University Of Connecticut |
Inhibitors of the anandamide transporter
|
US7897598B2
(en)
|
1998-06-09 |
2011-03-01 |
Alexandros Makriyannis |
Inhibitors of the anandamide transporter
|
US7161016B1
(en)
|
1998-11-24 |
2007-01-09 |
University Of Connecticut |
Cannabimimetic lipid amides as useful medications
|
US7276613B1
(en)
|
1998-11-24 |
2007-10-02 |
University Of Connecticut |
Retro-anandamides, high affinity and stability cannabinoid receptor ligands
|
FR2789079B3
(fr)
*
|
1999-02-01 |
2001-03-02 |
Sanofi Synthelabo |
Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
|
DE60042004D1
(de)
|
1999-04-28 |
2009-05-28 |
Toray Industries |
Stoffe zur enternung von cannabinoiden und säulen mit diesen stoffen zur entfernung von cannabinoiden
|
US7741365B2
(en)
*
|
1999-10-18 |
2010-06-22 |
University Of Connecticut |
Peripheral cannabinoid receptor (CB2) selective ligands
|
US8084467B2
(en)
*
|
1999-10-18 |
2011-12-27 |
University Of Connecticut |
Pyrazole derivatives as cannabinoid receptor antagonists
|
JP2003512357A
(ja)
*
|
1999-10-18 |
2003-04-02 |
ユニバーシティ オブ コネチカット |
カンナビノイドレセプタ拮抗物質としてのピラゾール誘導体
|
US7119108B1
(en)
*
|
1999-10-18 |
2006-10-10 |
University Of Connecticut |
Pyrazole derivatives as cannabinoid receptor antagonists
|
US6900236B1
(en)
|
1999-10-18 |
2005-05-31 |
University Of Connecticut |
Cannabimimetic indole derivatives
|
US7393842B2
(en)
*
|
2001-08-31 |
2008-07-01 |
University Of Connecticut |
Pyrazole analogs acting on cannabinoid receptors
|
CA2387764A1
(en)
|
1999-10-18 |
2001-04-26 |
University Of Connecticut |
Peripheral cannabinoid receptor (cb2) selective ligands
|
US6943266B1
(en)
|
1999-10-18 |
2005-09-13 |
University Of Connecticut |
Bicyclic cannabinoid agonists for the cannabinoid receptor
|
FR2800375B1
(fr)
|
1999-11-03 |
2004-07-23 |
Sanofi Synthelabo |
Derives tricycliques d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant
|
GB0002666D0
(en)
*
|
2000-02-04 |
2000-03-29 |
Univ London |
Blockade of voltage dependent sodium channels
|
US20020091114A1
(en)
|
2000-10-04 |
2002-07-11 |
Odile Piot-Grosjean |
Combination of a CB1 receptor antagonist and of sibutramine, the pharmaceutical compositions comprising them and their use in the treatment of obesity
|
JP2004532185A
(ja)
*
|
2001-01-26 |
2004-10-21 |
ユニバーシティ オブ コネチカット |
新規なカンナビミメティックリガンド
|
CA2436133A1
(en)
|
2001-01-29 |
2002-08-08 |
University Of Connecticut |
Receptor selective cannabimimetic aminoalkylindoles
|
US7507767B2
(en)
*
|
2001-02-08 |
2009-03-24 |
Schering Corporation |
Cannabinoid receptor ligands
|
US7067539B2
(en)
*
|
2001-02-08 |
2006-06-27 |
Schering Corporation |
Cannabinoid receptor ligands
|
US7057076B2
(en)
*
|
2001-07-13 |
2006-06-06 |
University Of Connecticut |
Bicyclic and tricyclic cannabinoids
|
AU2002319627A1
(en)
|
2001-07-20 |
2003-03-03 |
Merck And Co., Inc. |
Substituted imidazoles as cannabinoid receptor modulators
|
US6509367B1
(en)
*
|
2001-09-22 |
2003-01-21 |
Virginia Commonwealth University |
Pyrazole cannabinoid agonist and antagonists
|
EP1448557A4
(de)
*
|
2001-10-26 |
2005-02-02 |
Univ Connecticut |
Heteroindane: eine neue klasse hochwirksamer cannabimimetischer liganden
|
NZ532291A
(en)
|
2001-11-14 |
2005-11-25 |
Schering Corp |
Cannabinoid receptor ligands
|
US20040171613A1
(en)
*
|
2001-12-27 |
2004-09-02 |
Japan Tobacco Inc. |
Therapeutic agent for non-immediate type allergic diseases
|
US7351729B2
(en)
*
|
2002-03-08 |
2008-04-01 |
Signal Pharmaceuticals, Llc |
JNK inhibitors for use in combination therapy for treating or managing proliferative disorders and cancers
|
NZ534757A
(en)
|
2002-03-12 |
2006-07-28 |
Merck & Co Inc |
Substituted amides
|
CA2479618A1
(en)
|
2002-03-26 |
2003-10-09 |
William K. Hagmann |
Spirocyclic amides as cannabinoid receptor modulators
|
CA2479744A1
(en)
|
2002-03-28 |
2003-10-09 |
Paul E. Finke |
Substituted 2,3-diphenyl pyridines
|
EP1499306A4
(de)
|
2002-04-12 |
2007-03-28 |
Merck & Co Inc |
Bicyclische amide
|
US6825209B2
(en)
|
2002-04-15 |
2004-11-30 |
Research Triangle Institute |
Compounds having unique CB1 receptor binding selectivity and methods for their production and use
|
AU2003243637A1
(en)
|
2002-06-19 |
2004-01-06 |
Schering Corporation |
Cannabinoid receptor agonists
|
US7105526B2
(en)
|
2002-06-28 |
2006-09-12 |
Banyu Pharmaceuticals Co., Ltd. |
Benzimidazole derivatives
|
WO2004013120A1
(en)
|
2002-07-29 |
2004-02-12 |
F. Hoffmann-La Roche Ag |
Novel benzodioxoles
|
CA2496097A1
(en)
|
2002-08-23 |
2004-03-04 |
University Of Connecticut |
Keto cannabinoids with therapeutic indications
|
JP2006510597A
(ja)
*
|
2002-09-27 |
2006-03-30 |
メルク エンド カムパニー インコーポレーテッド |
置換ピリミジン類
|
EP1556373A1
(de)
*
|
2002-10-18 |
2005-07-27 |
Pfizer Products Inc. |
Cannabinoid rezeptorenliganden und ihre verwendung
|
US7129239B2
(en)
*
|
2002-10-28 |
2006-10-31 |
Pfizer Inc. |
Purine compounds and uses thereof
|
AR042120A1
(es)
|
2002-11-25 |
2005-06-08 |
Schering Corp |
Ligandos receptores cannabinoides
|
US7247628B2
(en)
*
|
2002-12-12 |
2007-07-24 |
Pfizer, Inc. |
Cannabinoid receptor ligands and uses thereof
|
DE60330392D1
(de)
|
2003-01-02 |
2010-01-14 |
Hoffmann La Roche |
Cb 1 rezeptor inversagonisten
|
DE60322114D1
(de)
|
2003-01-02 |
2008-08-21 |
Hoffmann La Roche |
Pyrrolyl-thiazole und ihre verwendung als inverse agonisten des cb 1 rezeptors
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
US7329658B2
(en)
*
|
2003-02-06 |
2008-02-12 |
Pfizer Inc |
Cannabinoid receptor ligands and uses thereof
|
US7176210B2
(en)
*
|
2003-02-10 |
2007-02-13 |
Pfizer Inc. |
Cannabinoid receptor ligands and uses thereof
|
TW200505902A
(en)
*
|
2003-03-20 |
2005-02-16 |
Schering Corp |
Cannabinoid receptor ligands
|
CA2522536A1
(en)
*
|
2003-04-21 |
2004-11-04 |
Daiichi Pharmaceutical Co., Ltd. |
Five-membered heterocyclic derivative
|
US7268133B2
(en)
*
|
2003-04-23 |
2007-09-11 |
Pfizer, Inc. Patent Department |
Cannabinoid receptor ligands and uses thereof
|
US20040214856A1
(en)
*
|
2003-04-23 |
2004-10-28 |
Pfizer Inc |
Cannabinoid receptor ligands and uses thereof
|
US7145012B2
(en)
*
|
2003-04-23 |
2006-12-05 |
Pfizer Inc. |
Cannabinoid receptor ligands and uses thereof
|
US7141669B2
(en)
*
|
2003-04-23 |
2006-11-28 |
Pfizer Inc. |
Cannabiniod receptor ligands and uses thereof
|
BRPI0410289A
(pt)
*
|
2003-05-07 |
2006-05-16 |
Pfizer Prod Inc |
ligantes do receptor de canabinóides e suas utilizações
|
US7232823B2
(en)
|
2003-06-09 |
2007-06-19 |
Pfizer, Inc. |
Cannabinoid receptor ligands and uses thereof
|
US20040259887A1
(en)
*
|
2003-06-18 |
2004-12-23 |
Pfizer Inc |
Cannabinoid receptor ligands and uses thereof
|
CN100368407C
(zh)
|
2003-06-20 |
2008-02-13 |
霍夫曼-拉罗奇有限公司 |
作为cb1受体反激动剂的2-酰氨基苯并噻唑
|
FR2856683A1
(fr)
*
|
2003-06-25 |
2004-12-31 |
Sanofi Synthelabo |
Derives de 4-cyanopyrazole-3-carboxamide, leur preparation et leur application en therapeutique
|
CA2551037A1
(en)
|
2003-09-22 |
2005-03-31 |
Banyu Pharmaceutical Co., Ltd. |
Novel piperidine derivative
|
KR100773650B1
(ko)
|
2003-12-08 |
2007-11-05 |
에프. 호프만-라 로슈 아게 |
신규한 싸이아졸 유도체
|
TW200522944A
(en)
|
2003-12-23 |
2005-07-16 |
Lilly Co Eli |
CB1 modulator compounds
|
JP4436369B2
(ja)
|
2004-01-28 |
2010-03-24 |
エフ.ホフマン−ラ ロシュ アーゲー |
スピロ−ベンゾジオキソール類およびそれらのcb1アンタゴニストとしての使用
|
GB0403779D0
(en)
*
|
2004-02-20 |
2004-03-24 |
Astrazeneca Ab |
Therapeutic agents
|
BRPI0507786A
(pt)
*
|
2004-02-20 |
2007-07-17 |
Astrazeneca Ab |
composto e sais farmaceuticamente aceitáveis do mesmo, formulação farmacêutica, uso de um composto, método de tratar uma doença, e, processo para a preparação de compostos
|
US20080125403A1
(en)
|
2004-04-02 |
2008-05-29 |
Merck & Co., Inc. |
Method of Treating Men with Metabolic and Anthropometric Disorders
|
ES2324720T3
(es)
|
2004-05-10 |
2009-08-13 |
F. Hoffmann-La Roche Ag |
Pirrol o imidazol amidas para tratar la obesidad.
|
ITMI20041032A1
(it)
|
2004-05-24 |
2004-08-24 |
Neuroscienze S C A R L |
Compositi farmaceutici
|
US7750158B2
(en)
*
|
2004-06-22 |
2010-07-06 |
Schering Corporation |
Cannabinoid receptor ligands
|
NZ552670A
(en)
|
2004-07-12 |
2010-02-26 |
Cadila Healthcare Ltd |
Tricyclic pyrazole derivatives as cannabinoid receptor modulators
|
US20060025448A1
(en)
|
2004-07-22 |
2006-02-02 |
Cadila Healthcare Limited |
Hair growth stimulators
|
FR2873372B1
(fr)
*
|
2004-07-22 |
2006-09-08 |
Sanofi Synthelabo |
Procede de preparation de derives n-piperidino-1,5- diphenylpyrazole-3-carboxamide
|
FR2874012B1
(fr)
*
|
2004-08-09 |
2008-08-22 |
Sanofi Synthelabo |
Derives de pyrrole, leur preparation et leur utlisation en therapeutique
|
RU2394027C2
(ru)
|
2004-10-27 |
2010-07-10 |
Ф. Хоффманн-Ля Рош Аг |
Новые индольные или бензимидазольные производные
|
US8394765B2
(en)
|
2004-11-01 |
2013-03-12 |
Amylin Pharmaceuticals Llc |
Methods of treating obesity with two different anti-obesity agents
|
ES2325773T5
(es)
|
2004-11-01 |
2014-02-24 |
Amylin Pharmaceuticals, Llc. |
Tratamiento de la obesidad y de los trastornos relacionados
|
EP1812418B1
(de)
|
2004-11-09 |
2010-10-27 |
F. Hoffmann-La Roche AG |
Dibenzosuberon-derivate
|
US20080146614A1
(en)
*
|
2004-12-23 |
2008-06-19 |
Leifeng Cheng |
Therapeutic Agents
|
US8853205B2
(en)
|
2005-01-10 |
2014-10-07 |
University Of Connecticut |
Heteropyrrole analogs acting on cannabinoid receptors
|
US8084451B2
(en)
|
2005-01-10 |
2011-12-27 |
University Of Connecticut |
Heteropyrrole analogs acting on cannabinoid receptors
|
WO2007022123A2
(en)
|
2005-08-11 |
2007-02-22 |
Amylin Pharmaceuticals, Inc. |
Hybrid polypeptides with selectable properties
|
ATE435207T1
(de)
|
2005-04-06 |
2009-07-15 |
Hoffmann La Roche |
Pyridin-3-carbonsäureamidderivate als cb1-inverse agonisten
|
US7737155B2
(en)
|
2005-05-17 |
2010-06-15 |
Schering Corporation |
Nitrogen-containing heterocyclic compounds and methods of use thereof
|
CA2609783A1
(en)
*
|
2005-05-27 |
2006-12-07 |
Pfizer Products Inc. |
Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss
|
RU2417985C2
(ru)
|
2005-05-30 |
2011-05-10 |
Баниу Фармасьютикал Ко., Лтд. |
Новые производные пиперидина
|
US7923465B2
(en)
|
2005-06-02 |
2011-04-12 |
Glenmark Pharmaceuticals S.A. |
Cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
|
CA2612079A1
(en)
*
|
2005-06-22 |
2006-12-28 |
F. Hoffmann-La Roche Ag |
(6-flu0r0-benz0[1,3] dioxolyl)-morpholin-4-yl-methanones and their use as cb1 ligands
|
EP1743890A1
(de)
*
|
2005-07-15 |
2007-01-17 |
Laboratorios Del Dr. Esteve, S.A. |
4,5-Dihydro-1H-Pyrazol-Derivative, Verfahren zur Herstellung und ihre Verwendung als Medikamente.
|
GB0514739D0
(en)
*
|
2005-07-19 |
2005-08-24 |
Astrazeneca Ab |
Therapeutic agents
|
GB0514738D0
(en)
*
|
2005-07-19 |
2005-08-24 |
Astrazeneca Ab |
Therapeutic agents
|
CA2518579A1
(en)
*
|
2005-08-05 |
2007-02-05 |
University Technologies International Inc. |
Method for appetite suppression
|
WO2007016771A1
(en)
*
|
2005-08-05 |
2007-02-15 |
Uti Limited Partnership |
Dosing regimen for weight loss
|
US20100216758A1
(en)
|
2005-08-10 |
2010-08-26 |
Makoto Ando |
Pyridone Compounds
|
EP2330125A3
(de)
|
2005-08-11 |
2012-12-12 |
Amylin Pharmaceuticals, Inc. |
Hybridpolypeptide mit auswählbaren Eigenschaften
|
MX2008001919A
(es)
*
|
2005-08-12 |
2008-03-24 |
Astrazeneca Ab |
Proceso para la preparacion de una dispersion estable de particulas submicronicas en un medio acuoso.
|
JPWO2007024004A1
(ja)
|
2005-08-24 |
2009-03-05 |
萬有製薬株式会社 |
フェニルピリドン誘導体
|
WO2007026215A1
(en)
*
|
2005-08-29 |
2007-03-08 |
Glenmark Pharmaceuticals S.A. |
Pyrazole derivatives as cannabinoid receptor ligands, pharmaceutical compositions containing? them, and processes for their preparation
|
EP1939194A4
(de)
|
2005-09-07 |
2010-12-08 |
Banyu Pharma Co Ltd |
Bicyclisches aromatisches substituiertes pyridon-derivat
|
EP1940842B1
(de)
|
2005-09-29 |
2012-05-30 |
Merck Sharp & Dohme Corp. |
Acylierte spiropiperidinderivate als modulatoren des melanocortin-4-rezeptors
|
AR056560A1
(es)
*
|
2005-10-06 |
2007-10-10 |
Astrazeneca Ab |
Pirrolopiridinonas como moduladores cb1
|
JP5069894B2
(ja)
*
|
2005-10-21 |
2012-11-07 |
田辺三菱製薬株式会社 |
ピラゾール化合物
|
CA2627139A1
(en)
|
2005-10-27 |
2007-05-03 |
Banyu Pharmaceutical Co., Ltd. |
Novel benzoxathiin derivative
|
EP1953165B1
(de)
|
2005-11-10 |
2012-02-01 |
Msd K.K. |
Aza-substituierte spiroderivate
|
CN100999517B
(zh)
*
|
2006-01-11 |
2010-12-15 |
北京摩力克科技有限公司 |
吡唑甲酰胺衍生物,药物组合物和其制备方法
|
CN101437398A
(zh)
|
2006-03-10 |
2009-05-20 |
詹里恩探索公司 |
用于治疗肥胖症的大麻素受体拮抗剂/反向激动剂
|
US20070287734A1
(en)
*
|
2006-06-09 |
2007-12-13 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted pyrazole compounds with cannabinoid receptor activity
|
US7629346B2
(en)
|
2006-06-19 |
2009-12-08 |
Hoffmann-La Roche Inc. |
Pyrazinecarboxamide derivatives as CB1 antagonists
|
EP2057144A4
(de)
*
|
2006-09-01 |
2010-06-02 |
Hetero Drugs Ltd |
Neue polymorphe aus rimonabant
|
EP2061783A2
(de)
*
|
2006-09-11 |
2009-05-27 |
Hetero Drugs Limited |
Verbessertes verfahren für rimonabant
|
US7781593B2
(en)
|
2006-09-14 |
2010-08-24 |
Hoffmann-La Roche Inc. |
5-phenyl-nicotinamide derivatives
|
EP2083831B1
(de)
|
2006-09-22 |
2013-12-25 |
Merck Sharp & Dohme Corp. |
Verfahren zur behandlung von fettsäure-synthese-hemmern
|
CA2664358A1
(en)
|
2006-09-28 |
2008-04-03 |
Banyu Pharmaceutical Co., Ltd. |
Diarylketimine derivative
|
JP5269795B2
(ja)
|
2006-09-29 |
2013-08-21 |
グリーン・クロス・コーポレイション |
カンナビノイドcb1受容体アンタゴニストとしてのヘテロアリール−ピラゾール誘導体
|
TW200848039A
(en)
*
|
2007-02-09 |
2008-12-16 |
Astrazeneca Ab |
Pharmaceutical compositions
|
WO2008102367A1
(en)
*
|
2007-02-19 |
2008-08-28 |
Darmesh Mahendrabhai Shah |
Process for preparation of pyrazole derivatives
|
EP2145884B1
(de)
|
2007-04-02 |
2014-08-06 |
Msd K.K. |
Indoledionderivat
|
JP4994295B2
(ja)
*
|
2007-04-20 |
2012-08-08 |
田辺三菱製薬株式会社 |
医薬組成物
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
EA020466B1
(ru)
|
2007-06-04 |
2014-11-28 |
Синерджи Фармасьютикалз Инк. |
Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний
|
FR2919868A1
(fr)
*
|
2007-08-06 |
2009-02-13 |
Sanofi Aventis Sa |
Le solvate de n,n-dimethyformamide de rimonabant, et son procede de preparation
|
FR2919861A1
(fr)
*
|
2007-08-06 |
2009-02-13 |
Sanofi Aventis Sa |
Le solvate d'isopranol de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
|
US8133904B2
(en)
|
2007-09-07 |
2012-03-13 |
Jenrin Discovery, Inc. |
Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
|
EA201070609A1
(ru)
*
|
2007-11-14 |
2010-12-30 |
Амилин Фармасьютикалз, Инк. |
Способы лечения ожирения и ассоциированных с ожирением заболеваний и расстройств
|
WO2009110510A1
(ja)
|
2008-03-06 |
2009-09-11 |
萬有製薬株式会社 |
アルキルアミノピリジン誘導体
|
JPWO2009119726A1
(ja)
|
2008-03-28 |
2011-07-28 |
Msd株式会社 |
メラニン凝集ホルモン受容体拮抗作用を有するジアリールメチルアミド誘導体
|
CA2726917C
(en)
|
2008-06-04 |
2018-06-26 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
AU2009261248A1
(en)
|
2008-06-19 |
2009-12-23 |
Banyu Pharmaceutical Co., Ltd. |
Spirodiamine-diarylketoxime derivative
|
CA2730603C
(en)
|
2008-07-16 |
2019-09-24 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
JPWO2010013595A1
(ja)
|
2008-07-30 |
2012-01-12 |
Msd株式会社 |
5員−5員又は5員−6員縮環シクロアルキルアミン誘導体
|
CN102264228A
(zh)
|
2008-10-22 |
2011-11-30 |
默沙东公司 |
用于抗糖尿病药的新的环状苯并咪唑衍生物
|
US8329914B2
(en)
|
2008-10-31 |
2012-12-11 |
Merck Sharp & Dohme Corp |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
US20110243940A1
(en)
|
2008-12-16 |
2011-10-06 |
Schering Corporation |
Bicyclic pyranone derivatives and methods of use thereof
|
US20110245209A1
(en)
|
2008-12-16 |
2011-10-06 |
Schering Corporation |
Pyridopyrimidine derivatives and methods of use thereof
|
WO2010079241A1
(es)
|
2009-01-12 |
2010-07-15 |
Fundacion Hospital Nacional De Paraplejicos Para La Investigacion Y La Integracion |
Uso de antagonistas y/o agonistas inversos de los receptores cb1 para la preparación de medicamentos que incrementen la excitabilidad de las motoneuronas
|
US10053444B2
(en)
|
2009-02-19 |
2018-08-21 |
University Of Connecticut |
Cannabinergic nitrate esters and related analogs
|
WO2011106273A1
(en)
|
2010-02-25 |
2011-09-01 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
CN102260246B
(zh)
*
|
2010-05-28 |
2014-08-13 |
范如霖 |
低毒性cb1受体抑制剂、其制备方法及其在制备戒毒、减肥或治疗糖尿病药物中的应用
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
US8410107B2
(en)
|
2010-10-15 |
2013-04-02 |
Hoffmann-La Roche Inc. |
N-pyridin-3-yl or N-pyrazin-2-yl carboxamides
|
US8669254B2
(en)
|
2010-12-15 |
2014-03-11 |
Hoffman-La Roche Inc. |
Pyridine, pyridazine, pyrimidine or pyrazine carboxamides as HDL-cholesterol raising agents
|
CA2826649C
(en)
|
2011-02-25 |
2016-07-26 |
Merck Sharp & Dohme Corp. |
Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
|
US20140045746A1
(en)
|
2012-08-02 |
2014-02-13 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
BR112015019836A2
(pt)
|
2013-02-22 |
2017-07-18 |
Merck Sharp & Dohme |
composto, composição farmacêutica, e, uso de um composto
|
US9650375B2
(en)
|
2013-03-14 |
2017-05-16 |
Merck Sharp & Dohme Corp. |
Indole derivatives useful as anti-diabetic agents
|
EP2970384A1
(de)
|
2013-03-15 |
2016-01-20 |
Synergy Pharmaceuticals Inc. |
Agonisten der guanylatcyclase und deren verwendungen
|
CA2905435A1
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
CN113388007A
(zh)
|
2013-06-05 |
2021-09-14 |
博士医疗爱尔兰有限公司 |
鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
EP3186242B1
(de)
|
2014-08-29 |
2021-10-06 |
Tes Pharma S.r.l. |
Inhibitoren von alpha-amino-beta-carboxymuconsäure semialdehyd-decarboxylase
|
EP3526199B1
(de)
|
2016-10-14 |
2022-04-13 |
Tes Pharma S.r.l. |
Inhibitoren der alpha-amino-beta-carboxymuconsäure-semialdehyddecarboxylase
|
US11072602B2
(en)
|
2016-12-06 |
2021-07-27 |
Merck Sharp & Dohme Corp. |
Antidiabetic heterocyclic compounds
|
CN113302189A
(zh)
|
2018-11-20 |
2021-08-24 |
Tes制药有限责任公司 |
α-氨基-β-羧基己二烯二酸半醛去羧酶的抑制剂
|
CN110372627B
(zh)
*
|
2019-07-04 |
2022-12-06 |
南昌大学 |
一种1,3,4-噁二唑衍生物及其制备方法和应用
|
CA3125847A1
(en)
|
2020-07-27 |
2022-01-27 |
Makscientific, Llc |
Process for making biologically active compounds and intermediates thereof
|
CN115636788A
(zh)
*
|
2022-10-31 |
2023-01-24 |
合肥工业大学 |
一种利莫那班n-甲基类似物的合成方法
|